Fenofibrate Attenuates Renal Tubular Cell Apoptosis by Up-Regulating MCAD in Diabetic Kidney Disease.
Chao TangXiaoqing DengJingru QuYahui MiaoLei TianMan ZhangXiaoyu LiBei SunLiming ChenPublished in: Drug design, development and therapy (2023)
Fenofibrate improves lipid accumulation and apoptosis through the AMPK/FOXA2/MCAD pathway. MCAD may be a potential therapeutic target of DKD, and the use of fenofibrate as a treatment for DKD warrants further study.